Live
Home·Deals·neurotechnology·Firefly Neuroscience Inc. acquires Evoke Neuroscience
SEO URLwww.firestrike.ai/deals/evoke-neuroscience-firefly-neuroscience-inc-acquisition-2026
acquisitionAnnounced · Mar 26, 2026neurotechnologySource · AdvertisementsArticle · Factual
Evoke Neuroscience
Firefly Neuroscience Inc.
Evoke Neuroscience · Firefly Neuroscience Inc.

Firefly Neuroscience Inc. acquires Evoke Neuroscience

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
Target
Evoke Neuroscience
Evoke Neuroscience
New York City, New York
Acquirer
Firefly Neuroscience Inc.
Firefly Neuroscience Inc.
Full Acquisition
Status
Completed

Firefly Neuroscience Inc. has completed its acquisition of Evoke Neuroscience, consolidating its foothold in the neurotechnology sector. The move, involving an undisclosed financial arrangement, signifies Firefly's strategic expansion as it aligns with its growth trajectory. The acquisition follows a notable 37.49% surge in Firefly's stock, reflecting heightened investor optimism regarding its technological advancements. Based in New York City, Evoke Neuroscience is anticipated to bring valuable assets and capabilities to Firefly's expanding portfolio.

The transaction's specifics, including the valuation, remain undisclosed, consistent with typical practices in the sector for sensitive financial details. With the acquisition now finalized, the integration of Evoke into Firefly's operations is expected to commence immediately. Firefly has not yet disclosed any plans for workforce integration or operational changes post-acquisition.

The acquisition bolsters Firefly's position in the competitive landscape of neurotechnology. By incorporating Evoke’s expertise, Firefly aims to enhance its product offering, particularly in cognitive monitoring and neural analytics. This strategic move is intended to accelerate the development of new neurotechnological solutions and strengthen Firefly's market presence. The increased stock price is an early indicator of investor confidence in Firefly’s direction and potential for future innovations in the space.

This acquisition also reflects broader trends in the neurotechnology market, where companies are increasingly consolidating resources to capitalize on growing demand for advanced cognitive health solutions. As competition intensifies, players like Firefly are actively pursuing strategic acquisitions to secure technological advantages and expand their capabilities.

Looking ahead, Firefly's integration of Evoke will be closely monitored. Attention will likely focus on how Firefly leverages Evoke's existing technologies and expertise, potentially influencing future market dynamics and competitors' strategies. No regulatory hurdles have been noted in connection with this acquisition, suggesting a smooth transition as Firefly progresses into its next phase of growth.

Deal timeline

Announced
Mar 26, 2026 · stockstotrade.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in neurotechnology. Figures and status may change as sources update.

Sources: stockstotrade.com · Primary article · FireStrike proprietary index